The prevalence of diabetes amongst young Emirati female adults in the United Arab Emirates: A cross-sectional study

V2CTX MXene-based hybrid sensor with high selectivity and ppb-level detection for acetone at room temperature

High-performance, room temperature-based novel sensing materials are one of the frontier research topics in the gas sensing field, and MXenes, a family of emerging 2D layered materials, has gained widespread attention due to their distinctive properties. In this work, we propose a chemiresistive gas sensor made from V₂CT_x MXene-derived, urchin-like V₂O₅ hybrid materials (V₂C/V₂O₅ MXene) for gas sensing applications at room temperature. The as-prepared sensor exhibited high performance when used as the sensing material for acetone detection at room temperature. Furthermore, the V₂C/V₂O₅ MXene-based sensor exhibited a higher response (S% = 11.9%) toward 15 ppm acetone than pristine multilayer V₂CT_x MXenes (S% = 4.6%). Additionally, the composite sensor demonstrated a low detection level at ppb levels (250 ppb) at room temperature, as well as high selectivity among different interfering gases, fast response-recovery time, good repeatability with minimal amplitude fluctuation, and excellent long-term stability. These improved sensing properties can be attributed to the possible formation of H-bonds in multilayer V₂C MXenes, the synergistic effect of the newly formed composite of urchin-like V₂C/V₂O₅ MXene sensor, and high charge carrier transport at the interface of V₂O₅ and V₂C MXene.

COVID-19 Case Management Outcomes Amongst Diabetes and Hypertensive Patients in the United Arab Emirates: A Prospective Study

The global pandemic of the novel Coronavirus infection 2019 (COVID-19) challenged the care of comorbid patients. The risk imposed by COVID-19 on diabetes patients is multisystemic, exponential, and involves glucose dysregulation. The increased burden for diabetes patients infected with COVID-19 is substantial in countries with a high prevalence of diabetics, such as the United Arab Emirates (UAE). This study aims to explore the prevalence of diabetes, clinical characteristic, and outcomes of patients admitted for COVID-19 treatment with or without a concurrent preadmission diagnosis of diabetes. A prospective study was performed on 1199 adults admitted with confirmed COVID-19 from December 2020 to April 2021 to a single hospital in the UAE. The study compared the demographics, clinical characteristics, and outcomes in COVID-19-infected patients with diabetes to patients without diabetes. The study endpoints include the development of new-onset diabetes, admission to ICU, trends in the blood glucose levels, and death. A total of 1199 patients (390 with diabetes) were included in the study. A diabetes prevalence was detected among 9.8% of the study population. Among the diabetes group, 10.8% were morbidly obese, 65.4% had associated hypertension, and 18.9% had coronary artery disease. Diabetes patients showed higher rates of ICU admission (11.1% vs. 7.1%), NIV requirement (9.6% vs. 6.4%), and intubation (5.45% vs. 2%) compared to the non-diabetes group. Advanced age was a predictor of a worsening COVID-19 course, while diabetes (p < 0.050) and hypertension (p < 0.025) were significant predictors of death from COVID-19. Nearly three-fourths (284 (73.4%)) of the diabetic patients developed worsened hyperglycemia as compared to one-fifth (171 (20.9%)) of the nondiabetic patients. New-onset diabetes was detected in 9.8% of COVID-19 patients. COVID-19 severity is higher in the presence of diabetes and is associated with worsening hyperglycemia and poor clinical outcomes. Preexisting hypertension is a predictor of COVID-19 severity and death.